Tag Archives: AbbVie

AbbVie settles trade secrets fight with Evolus, scoring $35M and royalties on Botox rival Jeuveau

AbbVie’s newest revenue streams come courtesy of Evolus and its Botox competitor Jeuveau.  To settle a long-running legal battle, Evolus will pay Allergan and its partner Medytox $ 35 million in cash, plus royalties on Jeuveau’s U.S. sales, according an Evolus SEC filing. The settlement ends all legal claims the trio had levied against one another… Read More »

AbbVie pegs growth to booming Skyrizi, Rinvoq in post-merger future. But neurology could be a ‘sleeper’

With its $ 63 billion merger with Allergan in the rearview, the new AbbVie is facing a major challenge as U.S. biosimilars for Humira cast a pall over the near-term future. But AbbVie figures its homegrown prospects will keep driving growth—and a couple of surprises from Allergan could make the forecast even rosier.  After six… Read More »